Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if JSPR is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
14 top institutions tracked
Last 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoverySentiment: neutral
Last trade: buy 85 days ago
Red flags: 0
43 filers reported a long position in JSPR for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Velan Capital Investment Management LP | $1.1M | 2.7M | Unchanged |
| ACORN CAPITAL ADVISORS, LLC | $604K | 1.4M | +1.9% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | $569.2K | 1.4M | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $493.4K | 1.2M | 0% |
| Rock Springs Capital Management LP | $463.4K | 1.1M | Unchanged |
| Carlyle Group Inc. | $448.9K | 1.1M | Unchanged |
| GSA CAPITAL PARTNERS LLP | $225K | 534.7K | +2,701.8% |
| MILLENNIUM MANAGEMENT LLC | $205K | 486.9K | -69.9% |
| Lion Point Capital, LP | $195.8K | 465K | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC | $111.1K | 263.8K | -17% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.